Last Updated: June 26, 2026

List of Excipients in API nebivolol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing nebivolol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 CELLULOSE, MICROCRYSTALLINE
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 CROSCARMELLOSE SODIUM
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 D&C RED NO. 27
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 FD&C BLUE NO. 2
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 FD&C YELLOW NO. 6
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 HYPROMELLOSE
Allergan Inc BYSTOLIC nebivolol hydrochloride 0456-1402 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing nebivolol

Company Ingredient NDC Excipient
Major Pharmaceuticals nebivolol 0904-7189 CELLULOSE, MICROCRYSTALLINE
Major Pharmaceuticals nebivolol 0904-7189 CROSCARMELLOSE SODIUM
Major Pharmaceuticals nebivolol 0904-7189 FD&C BLUE NO. 2
Major Pharmaceuticals nebivolol 0904-7189 FD&C YELLOW NO. 6
Major Pharmaceuticals nebivolol 0904-7189 HYPROMELLOSE 2910
Major Pharmaceuticals nebivolol 0904-7189 LACTOSE MONOHYDRATE
Major Pharmaceuticals nebivolol 0904-7189 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for nebivolol

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 27

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM PALMITOSTEARATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K30

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM LAURYL SULFOACETATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links